Al Janaby T, Khelwatty S, Bagwan I, Abbassi-Ghadi N, Modjtahedi H. Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma. World J Oncol [Internet]. 2025 Jun. 14 [cited 2025 Jul. 8];16(3):254-68. Available from: https://wjon.elmerpub.com/wjon/article/view/2552